BIA Separations, a biochromatography development and manufacturing company, has appointed Pete Gagnon as chief scientific officer. In his new role, he will drive the company’s new product and applications development, with a focus on the purification and increased safety of products for gene therapy, oncolytic vaccines, exosomes, and more.   Gagnon brings over 30 years of experience in the biotech industry, where the majority of his experience was in the development of commercial purific...